Lymphoma

N-AVD Yields High Progression-Free Survival in Teens With Hodgkin Lymphoma

Physician’s Briefing

N-AVD Yields High Progression-Free Survival in Teens With Hodgkin Lymphoma

22 Jan 2026

1 min read

FDA Approves Breyanzi for Relapsed, Refractory Marginal Zone Lymphoma

Physician’s Briefing

FDA Approves Breyanzi for Relapsed, Refractory Marginal Zone Lymphoma

15 Dec 2025

1 min read

FDA Approves Expanded Indication for Jaypirca

Physician’s Briefing

FDA Approves Expanded Indication for Jaypirca

09 Dec 2025

1 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com